• Something wrong with this record ?

The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions

P. Habal, K. Jankovicova, N. Omran, K. Kondelkova, J. Krejsek, J. Mandak

. 2013 ; 157 (4) : 311-315. [pub] 20121207

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Malignant pleural effusions accumulate in the space between the visceral (inner) layer covering the lungs and the parietal (outer) layer covering the chest wall. Larger effusions compress the pulmonary parenchyma resulting in increasing dyspnoea. Treatment is always local and palliative. Among others, chemical pleurodesis using talc can be performed in selected patients. Talc is hydrated magnesium silicate (chemically H₂Mg₃(SiO₃)₄) and has been used for pleurodesis since 1935. Videothoracoscopic talc powder insufflation (talc poudrage) is the most effective.However, markers of inflammatory reactions to extraneous substances like talc are not fully understood. The aim of this study was to assess the course of local inflammatory changes in the pleural cavity after talc insufflation. METHODS: The Department of Cardiac Surgery of the Faculty of Medicine and University Hospital in Hradec Kralove, treated 47 patients aged 65 on average; 29 males and 18 females with proven recurrent malignant pleural effusion of various aetiologies from January 2009 to December 2010. They were retrospectively divided into group A (40 patients) without recurring effusion, and group B (7 patients) with recurring effusion and the need for thoracentesis or chest drainage during the 9-month monitoring. RESULTS: Major findings were made in soluble forms of cell receptors. Group B showed statistically higher levels of the anti-inflammatory form of sCD-163 receptor in pleural fluid before the talc poudrage. This showed limited ability to create an adequate inflammatory response to external stimuli. This group also showed lower levels of the inflammatory form of sTLR-2 receptor immediately after the talc insufflation. This revealed low local reactivity to external stimuli. The effect of the treatment was not influenced by morphologic tumour type. No statistically significant differences in postoperative complications were found. This confirmed the safety of both videothoracoscopy and treatment. CONCLUSIONS: There was no correlation between the type of malignant affection and the outcome of the chemical pleurodesis. Patients with relapsing effusion have higher values of concentration of anti-inflammatory sCD-163 in pleural fluid even before the application of talc, and lower levels of concentration of inflammatory sTLR-2 immediately after application of talc.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15026695
003      
CZ-PrNML
005      
20150818085843.0
007      
ta
008      
150811s2013 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2012.095 $2 doi
035    __
$a (PubMed)23235721
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Habal, Petr $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic $7 xx0063394
245    14
$a The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions / $c P. Habal, K. Jankovicova, N. Omran, K. Kondelkova, J. Krejsek, J. Mandak
520    9_
$a BACKGROUND: Malignant pleural effusions accumulate in the space between the visceral (inner) layer covering the lungs and the parietal (outer) layer covering the chest wall. Larger effusions compress the pulmonary parenchyma resulting in increasing dyspnoea. Treatment is always local and palliative. Among others, chemical pleurodesis using talc can be performed in selected patients. Talc is hydrated magnesium silicate (chemically H₂Mg₃(SiO₃)₄) and has been used for pleurodesis since 1935. Videothoracoscopic talc powder insufflation (talc poudrage) is the most effective.However, markers of inflammatory reactions to extraneous substances like talc are not fully understood. The aim of this study was to assess the course of local inflammatory changes in the pleural cavity after talc insufflation. METHODS: The Department of Cardiac Surgery of the Faculty of Medicine and University Hospital in Hradec Kralove, treated 47 patients aged 65 on average; 29 males and 18 females with proven recurrent malignant pleural effusion of various aetiologies from January 2009 to December 2010. They were retrospectively divided into group A (40 patients) without recurring effusion, and group B (7 patients) with recurring effusion and the need for thoracentesis or chest drainage during the 9-month monitoring. RESULTS: Major findings were made in soluble forms of cell receptors. Group B showed statistically higher levels of the anti-inflammatory form of sCD-163 receptor in pleural fluid before the talc poudrage. This showed limited ability to create an adequate inflammatory response to external stimuli. This group also showed lower levels of the inflammatory form of sTLR-2 receptor immediately after the talc insufflation. This revealed low local reactivity to external stimuli. The effect of the treatment was not influenced by morphologic tumour type. No statistically significant differences in postoperative complications were found. This confirmed the safety of both videothoracoscopy and treatment. CONCLUSIONS: There was no correlation between the type of malignant affection and the outcome of the chemical pleurodesis. Patients with relapsing effusion have higher values of concentration of anti-inflammatory sCD-163 in pleural fluid even before the application of talc, and lower levels of concentration of inflammatory sTLR-2 immediately after application of talc.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a CD antigeny $x analýza $7 D015703
650    _2
$a antigeny diferenciační myelomonocytární $x analýza $7 D015214
650    _2
$a biologické markery $x analýza $7 D015415
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a maligní pleurální výpotek $x imunologie $x terapie $7 D016066
650    12
$a pleurodéza $7 D018700
650    _2
$a receptory buněčného povrchu $x analýza $7 D011956
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a mastek $x imunologie $x terapeutické užití $7 D013627
650    _2
$a toll-like receptor 2 $x analýza $7 D051195
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jankovičová, Karolína $7 stk2008428938 $u Department of Clinical Immunology and Allergy, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove
700    1_
$a Omran, Nedal $7 xx0236392 $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic
700    1_
$a Kondelková, Kateřina $7 _AN046541 $u Department of Clinical Immunology and Allergy, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove
700    1_
$a Krejsek, Jan, $d 1958- $7 nlk19990073429 $u Department of Clinical Immunology and Allergy, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove
700    1_
$a Manďák, Jiří, $d 1958- $7 mzk2006337422 $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 157, č. 4 (2013), s. 311-315
856    41
$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20150811 $b ABA008
991    __
$a 20150812131405 $b ABA008
999    __
$a ok $b bmc $g 1087905 $s 909731
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 157 $c 4 $d 311-315 $e 20121207 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20150811

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...